Crescita Therapeutics Inc Capital Reinvestment Ratio
Crescita Therapeutics Inc capital reinvestment ratio. Crescita Therapeutics Inc (CTX) has a Capital Reinvestment Ratio of 1.74x as of December 2025, meaning it reinvests 2% of its operating cash flow (CA$416.00K) in capital expenditures (CA$724.00K). Check CTX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Crescita Therapeutics Inc (2019–2025)
Capital reinvestment ratio of Crescita Therapeutics Inc from 2019 to 2025. This chart tracks Crescita Therapeutics Inc's Capital Reinvestment Ratio across 5 annual periods. Also explore CTX net asset momentum to track the company's year-over-year net asset growth rate.
Crescita Therapeutics Inc Capital Reinvestment Ratio by Year (2019–2025)
Crescita Therapeutics Inc capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see Crescita Therapeutics Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CA$1.07 Million | CA$333.00K | ▼ -28.6% |
| 2024 | 0.43x | CA$2.73 Million | CA$1.19 Million | ▲ +578.8% |
| 2023 | 0.06x | CA$2.08 Million | CA$133.00K | ▲ +508.9% |
| 2020 | 0.01x | CA$5.61 Million | CA$59.00K | ▼ -74.0% |
| 2019 | 0.04x | CA$5.31 Million | CA$215.00K | — |